(Drug Name) (Drug Form) (Drug Strength)
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

FARYDAK: Oral capsule (10mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

PANOBINOSTAT (pan oh bin oh stat) is a chemotherapy drug that targets a specific protein within cancer cells and stops the cancer cells from growing. It is used to treat multiple myeloma.

In-Depth Information

FARYDAK 10mg Capsule

NDC: 000780650
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Multiple Myeloma

Sometimes used for but not FDA approved for the following conditions:
Cutaneous T-cell Lymphoma (CTCL)

Storage Information
Store in original package until time of use
Protect from light
Store between 68 to 77 degrees F, excursions permitted 59 to 86 degrees F
FARYDAK 10mg Capsule

Reported Side Effects for FARYDAK 10mg Capsule

Underactive Thyroid Incidence:
<10.0%*
Severity: MODERATE
Onset: DELAYED
Inability To Sleep Incidence:
<10.0%*
Severity: MILD
Onset: EARLY
Not Breathing Incidence:
<12.0%*
Severity: SEVERE
Onset: RAPID
Postural Low Blood Pressure Incidence:
<10.0%*
Severity: MODERATE
Onset: DELAYED
Kidney Failure Incidence:
<10.0%*
Severity: SEVERE
Onset: DELAYED
Shaking Incidence:
<10.0%*
Severity: MILD
Onset: EARLY
Uncontrolled Urination Incidence:
<10.0%*
Severity: MODERATE
Onset: EARLY
Rapid Heart Rate Incidence:
<12.0%*
Severity: SEVERE
Onset: EARLY
Dry Mouth Incidence:
<10.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
<10.0%*
Severity: MILD
Onset: EARLY
Liver Infection Incidence:
<10.0%*
Severity: MODERATE
Onset: DELAYED
Increased Blood Sugar Incidence:
<10.0%*
Severity: MODERATE
Onset: DELAYED
Skin Rash Incidence:
<10.0%*
Severity: MILD
Onset: EARLY
Rapid Heart Rate Incidence:
<10.0%*
Severity: MODERATE
Onset: EARLY
Long Qt Syndrome Incidence:
<12.0%*
Severity: MODERATE
Onset: RAPID
Fainting Incidence:
<10.0%*
Severity: MILD
Onset: EARLY
Feeling Sick Incidence:
<25.0%*
Severity: SEVERE
Onset: EARLY
Weakness Incidence:
<25.0%*
Severity: SEVERE
Onset: DELAYED
Very Rapid Heart Rate Incidence:
<12.0%*
Severity: SEVERE
Onset: EARLY
Inflammation Of The Lip Incidence:
<10.0%*
Severity: MILD
Onset: DELAYED
Chills Incidence:
<10.0%*
Severity: MILD
Onset: RAPID
Lightheadedness Incidence:
<10.0%*
Severity: MILD
Onset: EARLY
Metallic Taste Incidence:
<10.0%*
Severity: MILD
Onset: EARLY
Elevated Hepatic Enzymes Incidence:
<10.0%*
Severity: MODERATE
Onset: DELAYED
Skin Redness Incidence:
<10.0%*
Severity: MODERATE
Onset: EARLY
Fluid Retention Incidence:
<10.0%*
Severity: MODERATE
Onset: DELAYED
Tiredness Incidence:
<25.0%*
Severity: SEVERE
Onset: EARLY
Irregular Heart Beat Incidence:
<12.0%*
Severity: SEVERE
Onset: EARLY
Irregular Heart Rate Incidence:
<12.0%*
Severity: SEVERE
Onset: EARLY
Slow Heart Beat Incidence:
<12.0%*
Severity: SEVERE
Onset: RAPID
Suddenly Stopped Heart Incidence:
<12.0%*
Severity: SEVERE
Onset: EARLY
Inflamed Colon Incidence:
<10.0%*
Severity: MODERATE
Onset: DELAYED
Cough Incidence:
<10.0%*
Severity: MILD
Onset: DELAYED
Dehydration Incidence:
<10.0%*
Severity: MODERATE
Onset: DELAYED
Wheezing Incidence:
<10.0%*
Severity: MODERATE
Onset: RAPID
Upset Stomach Incidence:
<10.0%*
Severity: MILD
Onset: EARLY
Shortness Of Breath Incidence:
<10.0%*
Severity: MODERATE
Onset: EARLY
Tired Incidence:
<25.0%*
Severity: SEVERE
Onset: EARLY
Gas Incidence:
<10.0%*
Severity: MILD
Onset: EARLY
Inflamed Stomach Incidence:
<10.0%*
Severity: MODERATE
Onset: DELAYED
Low Blood Pressure Incidence:
<10.0%*
Severity: MODERATE
Onset: RAPID
Rapid Heart Rate Incidence:
<12.0%*
Severity: MODERATE
Onset: RAPID
Skin Ulcer Incidence:
<10.0%*
Severity: MODERATE
Onset: DELAYED
Low Magnesium Levels Incidence:
<10.0%*
Severity: MODERATE
Onset: DELAYED
Rapid Heart Rate Incidence:
<3.0%*
Severity: SEVERE
Onset: EARLY
High Uric Acid Level Incidence:
<10.0%*
Severity: MODERATE
Onset: DELAYED
High Blood Pressure Incidence:
<10.0%*
Severity: MODERATE
Onset: EARLY
Headache Incidence:
<10.0%*
Severity: MILD
Onset: EARLY
Fever Incidence:
1.0%*
Severity: SEVERE
Onset: EARLY
High Bilirubin Level Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Weight Loss Incidence:
2.0%*
Severity: SEVERE
Onset: DELAYED
Fluid Retention Incidence:
2.0%*
Severity: SEVERE
Onset: DELAYED
Low Albumin In Blood Incidence:
2.0%*
Severity: SEVERE
Onset: DELAYED
Decreased Appetite Incidence:
3.0%*
Severity: SEVERE
Onset: DELAYED
Bleeding Incidence:
4.0%*
Severity: SEVERE
Onset: EARLY
High Magnesium Level Incidence:
5.0%*
Severity: SEVERE
Onset: DELAYED
Low Calcium Levels Incidence:
5.0%*
Severity: SEVERE
Onset: DELAYED
Upset Stomach Incidence:
6.0%*
Severity: SEVERE
Onset: EARLY
Vomiting Incidence:
7.0%*
Severity: SEVERE
Onset: EARLY
Low Blood Sodium Levels Incidence:
13.0%*
Severity: SEVERE
Onset: DELAYED
Low Potassium Levels Incidence:
18.0%*
Severity: SEVERE
Onset: DELAYED
Anemia Incidence:
18.0%*
Severity: SEVERE
Onset: DELAYED
Low Phosphate Level Incidence:
20.0%*
Severity: SEVERE
Onset: DELAYED
Low White Blood Cell Counts Incidence:
23.0%*
Severity: SEVERE
Onset: DELAYED
Loose Stools Incidence:
25.0%*
Severity: SEVERE
Onset: EARLY
High Phosphate Levels Incidence:
27.0%*
Severity: MODERATE
Onset: DELAYED
Infection Incidence:
31.0%*
Severity: SEVERE
Onset: DELAYED
Low White Blood Cells Incidence:
34.0%*
Severity: SEVERE
Onset: DELAYED
Low Lymphocytes Incidence:
53.0%*
Severity: SEVERE
Onset: DELAYED
Low Platelet Count Incidence:
67.0%*
Severity: SEVERE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for FARYDAK 10mg Capsule

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Major Lifestyle Interaction
Grapefruit juice and FARYDAK 10mg Capsule(Panobinostat)
Grapefruit juice and Panobinostat(Panobinostat)
Do not eat grapefruit or drink grapefruit juice with panobinostat. This fruit can increase the levels of panobinostat in your body and you may experience more side effects.
Pregnancy & Lactation Information
Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with FARYDAK

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5